TY - JOUR
T1 - Focus groups on digital cognitive assessment in the context of Alzheimer's disease
AU - van der Landen, Sophie M.
AU - van den Berg, Rosanne L.
AU - Keijzer, Matthijs J.
AU - van Liere, Mariska N.
AU - de Boer, Casper
AU - Visser, Leonie N.C.
AU - van der Flier, Wiesje M.
AU - Rhodius-Meester, Hanneke F.M.
AU - Sikkes, Sietske A.M.
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/1/1
Y1 - 2025/1/1
N2 - Introduction: Digital cognitive assessments (DCAs) may facilitate early recognition of cognitive decline in the context of Alzheimer's disease (AD). While DCAs are increasingly emerging, they are often not used in practice. We assessed facilitators and barriers of using DCAs according to older individuals and patients. Methods: In five focus groups, we presented three different DCAs to older individuals with unimpaired cognition (n = 14), subjective cognitive decline (n = 11) and mild cognitive impairment with biomarker-confirmed AD (n = 4) and their caregivers (n = 2). Participants discussed facilitators and barriers that could influence the use of DCAs. Focus groups were recorded, and transcripts were analysed using thematic analysis. Results: Three main themes were identified: (1) test motivation (‘Do I want to know my brain health?’), facilitated by early disease recognition, while impeded by fear of dementia; (2) digital test suitability (‘Do I want to use a digital test?’), enabling at-home testing, while lacking personal contact; and (3) digital test characteristics (‘What makes a digital test a good test for me?’), where user-friendliness was emphasized as a key facilitator to overcome digital incompetence. Discussion: Participants recognized the added value of DCAs, and multiple factors were identified as facilitators and barriers for their use. Similar factors could be a barrier for one, yet facilitated others, underlining the need for a personalized approach. Strategies to minimize barriers and exploit facilitators would ultimately foster implementation.
AB - Introduction: Digital cognitive assessments (DCAs) may facilitate early recognition of cognitive decline in the context of Alzheimer's disease (AD). While DCAs are increasingly emerging, they are often not used in practice. We assessed facilitators and barriers of using DCAs according to older individuals and patients. Methods: In five focus groups, we presented three different DCAs to older individuals with unimpaired cognition (n = 14), subjective cognitive decline (n = 11) and mild cognitive impairment with biomarker-confirmed AD (n = 4) and their caregivers (n = 2). Participants discussed facilitators and barriers that could influence the use of DCAs. Focus groups were recorded, and transcripts were analysed using thematic analysis. Results: Three main themes were identified: (1) test motivation (‘Do I want to know my brain health?’), facilitated by early disease recognition, while impeded by fear of dementia; (2) digital test suitability (‘Do I want to use a digital test?’), enabling at-home testing, while lacking personal contact; and (3) digital test characteristics (‘What makes a digital test a good test for me?’), where user-friendliness was emphasized as a key facilitator to overcome digital incompetence. Discussion: Participants recognized the added value of DCAs, and multiple factors were identified as facilitators and barriers for their use. Similar factors could be a barrier for one, yet facilitated others, underlining the need for a personalized approach. Strategies to minimize barriers and exploit facilitators would ultimately foster implementation.
KW - Alzheimer's disease
KW - Digital cognitive assessment
KW - early disease detection
KW - end user perspectives
KW - focus groups
KW - patient perspectives
UR - http://www.scopus.com/inward/record.url?scp=85219561597&partnerID=8YFLogxK
U2 - 10.1177/20552076251318903
DO - 10.1177/20552076251318903
M3 - Article
AN - SCOPUS:85219561597
SN - 2055-2076
VL - 11
JO - DIGITAL HEALTH
JF - DIGITAL HEALTH
ER -